Home LiteratureArticle Details
PMID: 2878881 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Molecular basis for the pathological actions of Clostridium perfringens iota toxin.

Infection and immunity ·Vol. 55 ·No. 1 ·1987-01-00 ·Pages 118-22

Simpson LL, Stiles BG, Zepeda HH, Wilkins TD

Abstract

Clostridium perfringens type E iota toxin is composed of two separate and independent polypeptide chains that act synergistically in mouse lethal assays. The light chain is an enzyme that mono(ADP-ribosyl)ates certain amino acids. The enzyme displays substantial activity when homopoly-L-arginine is used as a substrate, but it shows little activity when polyasparagine, polylysine or polyglutamic acid are used. In keeping with the properties of an ADP-ribosylating enzyme, the toxin possesses the following characteristics. It produces incorporation of radioactivity into polyarginine when adenine-labeled NAD is used, but radioactivity is not incorporated when nicotinamide-labeled NAD is used. Irrespective of labeling, enzymatic activity is accompanied by the release of free nicotinamide. After incorporation of ADP-ribose groups into polyarginine, enzymatic and chemical techniques can be used to release the incorporated material. Snake venom phosphodiesterase releases mainly AMP; hydroxylamine releases AMP and ADP-ribose. The heavy chain of iota toxin has little or no enzyme activity, and it does not substantially affect the enzyme activity of the light chain. The heavy chain may be a binding component that directs the toxin to vulnerable cells. The data suggest that iota toxin is a representative of a novel class of ADP-ribosylating toxins.

MeSH Terms
ADP Ribose Transferases Bacterial Toxins/metabolism,toxicity Clostridium perfringens/pathogenicity Hydroxylamine Hydroxylamines/pharmacology Kinetics NAD/metabolism Niacinamide/pharmacology Pentosyltransferases/metabolism Peptides/metabolism
Chemicals
Bacterial Toxins Hydroxylamines Peptides iota toxin, Clostridium perfringens NAD polyarginine Niacinamide Hydroxylamine ADP Ribose Transferases Pentosyltransferases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Simpson L L
Stiles B G
Zepeda H H
Wilkins T D
References (29)
29 references, click to expand
  1. Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen.
    J Clin Invest. 1978 Aug;62(2):281-5 PMID: 209060
  2. Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants.
    Infect Immun. 1978 May;20(2):552-8 PMID: 669812
  3. Current state of the art in the HPLC analyses of free nucleotides, nucleosides, and bases in biological fluids.
    Adv Chromatogr. 1980;18:101-38 PMID: 6994448
  4. The susceptibility of the mallard duck (Anas platyrhynchos) to Clostridium botulinum C2 toxin.
    Jpn J Med Sci Biol. 1980 Apr;33(2):81-6 PMID: 7412022
  5. Clostridium perfringens toxins (type A, B, C, D, E).
    Pharmacol Ther. 1980;10(3):617-55 PMID: 6255496
  6. Crystallization and properties of staphylococcal leukocidin.
    Biochim Biophys Acta. 1980 Nov 17;633(1):33-44 PMID: 6778510
  7. Evidence that botulinum C2 toxin has two dissimilar components.
    Infect Immun. 1980 Aug;29(2):390-4 PMID: 7011974
  8. Purification and characterization of two components of botulinum C2 toxin.
    Infect Immun. 1980 Dec;30(3):668-73 PMID: 6785232
  9. Anthrax toxin.
    Pharmacol Ther. 1981;12(3):501-13 PMID: 7025030
  10. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.
    Proc Natl Acad Sci U S A. 1982 May;79(10):3129-33 PMID: 6954463
  11. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.
    Proc Natl Acad Sci U S A. 1982 May;79(10):3162-6 PMID: 6285339
  12. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins.
    J Pharmacol Exp Ther. 1982 Dec;223(3):695-701 PMID: 6292397
  13. Lethal and vascular permeability activities of botulinum C2 toxin induced by separate injections of the two toxin components.
    Infect Immun. 1983 Apr;40(1):336-9 PMID: 6832833
  14. Response of mouse intestinal loop to botulinum C2 toxin: enterotoxic activity induced by cooperation of nonlinked protein components.
    Infect Immun. 1983 May;40(2):691-5 PMID: 6341246
  15. Molecular basis for the pharmacological actions of Clostridium botulinum type C2 toxin.
    J Pharmacol Exp Ther. 1984 Sep;230(3):665-9 PMID: 6236295
  16. Quantification of protein-bound ADP-ribosyl and (ADP-ribosyl)n residues.
    Methods Enzymol. 1984;106:472-82 PMID: 6493065
  17. Binding of the two components of C2 toxin to epithelial cells and brush borders of mouse intestine.
    Infect Immun. 1985 Jun;48(3):769-75 PMID: 3888843
  18. Clostridial toxins active locally in the gastrointestinal tract.
    Ciba Found Symp. 1985;112:230-41 PMID: 2861069
  19. ADP-ribosylation.
    Annu Rev Biochem. 1985;54:73-100 PMID: 3927821
  20. ADP-ribosylation of nonmuscle actin with component I of C2 toxin.
    Biochem Biophys Res Commun. 1986 Apr 29;136(2):802-6 PMID: 3518719
  21. Botulinum C2 toxin ADP-ribosylates actin.
    Nature. 1986 Jul 24-30;322(6077):390-2 PMID: 3736664
  22. Some properties of the iota-toxin of Clostridium welchii, including its action on capillary permeability.
    J Pathol Bacteriol. 1961 Apr;81:481-93 PMID: 13696198
  23. A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D.
    J Immunol. 1950 Aug;65(2):175-83 PMID: 15436997
  24. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  25. Adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis by diphtheria toxin.
    J Biol Chem. 1971 Jul 10;246(13):4251-60 PMID: 4326212
  26. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.
    Proc Natl Acad Sci U S A. 1975 Jun;72(6):2284-8 PMID: 166383
  27. The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin.
    Biochim Biophys Acta. 1977 Aug 11;483(2):248-57 PMID: 196649
  28. Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system.
    Proc Natl Acad Sci U S A. 1978 Jun;75(6):2669-73 PMID: 208069
  29. ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.
    Proc Natl Acad Sci U S A. 1978 Jul;75(7):3050-4 PMID: 210449
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1987-01-00
Pages
118-22
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC260288
Subset
IM
Grants
NIAID NIH HHS · AI-15749 · United States
NINDS NIH HHS · NS-22153 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com